Dental Care Clinics in Rawlins, WY Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Curtis T. Stoddard, D.m.d., P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1719 Edinburgh St, Rawlins, WY 82301 Phone: 307-324-6200 |
Davidson Family Dental/rawlins Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1101 W Spruce St, Rawlins, WY 82301 Phone: 307-324-3839 |
Aspen Family Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1101 W Spruce St, Rawlins, WY 82301 Phone: 307-324-3839 |
Aspen Family Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1101 W Spruce St, Rawlins, WY 82301 Phone: 307-324-3839 Fax: 307-324-3399 |
News Archive
Melatonin pre-treatment greatly increases cell survival, say researchers
When melatonin, a hormone secreted by the pineal gland, was used as a pre-treatment for mesenchymal stem cells prior to their transplantation into the brains of laboratory animals to repair damage from stroke, researchers in China found that the stem cells survived longer after transplantation. Previous studies had shown that 80 percent of transplanted MSCs died within 72 hours of transplantation.
Talyst launches new AutoPack for oral solid medications
Talyst, a leader in pharmacy automation, announces its newest AutoPack, which automates packaging for oral solid medications.
Cell Therapeutics announces submission of MAA to European Medicines Agency for Pixuvri
Cell Therapeutics, Inc. announced today that it has submitted a Marketing Authorization Application to the European Medicines Agency for Pixuvri (pixantrone dimaleate) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's lymphoma.
Swedish HIV vaccine study shows prmoise
A Swedish HIV vaccine study conducted by researchers at Karolinska Institutet (KI), Karolinska University Hospital and the Swedish Institute for Infectious Disease Control (SMI) has produced surprisingly good results.
Champions Biotechnology expands collaboration to accelerate oncology drug development
Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an agreement with Ortho Biotech Oncology Research & Development, a Division of Janssen Pharmaceutica NV, for the evaluation of a novel preclinical oncology therapeutic in Champions' Biomerk Tumorgraft(TM) platform.
› Verified 8 days ago